Mycosis Fungoides Clinical Trials

A listing of Mycosis Fungoides medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Austria

UPDATED

Graz

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

UPDATED

Wien

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

Belgium

UPDATED

Brussels

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

UPDATED

Leuven

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

France

UPDATED

Bordeaux

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

UPDATED

Clermont-Ferrand

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

UPDATED

Lyon

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

UPDATED

Paris

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

UPDATED

Reims

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

Germany

UPDATED

Berlin

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

UPDATED

Bochum

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

UPDATED

Buxtehude

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

UPDATED

Cologne

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

UPDATED

Dortmund

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

View More ▼

UPDATED

Erfurt

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

UPDATED

Essen

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

UPDATED

Gera

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

UPDATED

Karlsruhe

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

UPDATED

Kiel

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

UPDATED

Krefeld

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

UPDATED

Lübeck

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

UPDATED

Ludwigshafen

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

UPDATED

Mainz

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

UPDATED

Mannheim

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

UPDATED

Minden

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

UPDATED

Munich

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

UPDATED

Tübingen

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

UPDATED

Ulm

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

UPDATED

Würzburg

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

Italy

UPDATED

Bologna

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

UPDATED

Milano

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

UPDATED

Roma

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

UPDATED

Turin

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

Netherlands

UPDATED

Leiden

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

Poland

UPDATED

Bydgoszcz

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

UPDATED

Gdansk

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

UPDATED

Kraków

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

UPDATED

Łódź

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

UPDATED

Warsaw

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

View More ▼

UPDATED

Wrocław

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

Spain

UPDATED

Barcelona

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

UPDATED

Barcelona

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

UPDATED

Madrid

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

UPDATED

Valencia

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

Switzerland

UPDATED

Bern

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

UPDATED

St. Gallen

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

UPDATED

Zürich

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

United Kingdom

UPDATED

Birmingham

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

UPDATED

Glasgow

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous

UPDATED

London

Patients are needed to participate in a clinical research study evaluating resminostat and Placebo for the treatment of Mycosis Fungoides, Sezary Syndrome or Lymphoma, T-Cell, Cutaneous